tm
Seeing Is Believing
tm
Seeing Is Believing
VBLT is currently covered by 2 analysts with an average price target of $10.93. This is a potential upside of $8.17 (296.01%) from yesterday's end of day stock price of $2.76.
Vascular Biogenics Ltd's activity chart (see below) currently has 7 price targets and 12 ratings on display. The stock rating distribution of VBLT is 33.33% BUY and 66.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 155.25 days.
Highest price target for VBLT is $2, Lowest price target is $2, average price target is $10.93.
Most recent stock forecast was given by MATTHEW BARCUS from CHARDAN CAPITAL on 21-Jul-2022. First documented stock forecast 20-Aug-2015.
Currently out of the existing stock ratings of VBLT, 1 are a BUY (33.33%), 2 are a HOLD (66.67%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
1 years 9 months 2 days ago
1/1 (100%)
$3.37 (206.75%)
532
Hold
1 years 9 months 3 days ago
1/2 (50%)
$9.48 (151.49%)
89
Hold
1 years 9 months 3 days ago
0/1 (0%)
$6.9 (168.29%)
Buy
17
$14.24 (515.94%)
22
7 years 8 months 8 days ago
0/5 (0%)
$12.94 (318.72%)
What is VBLT (Vascular Biogenics Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on VBLT (Vascular Biogenics Ltd) with a proven track record?
Which analyst has the current lower performing score on VBLT (Vascular Biogenics Ltd) with a proven track record?
Which analyst has the most public recommendations on VBLT (Vascular Biogenics Ltd)?
Which analyst is the currently most bullish on VBLT (Vascular Biogenics Ltd)?
Which analyst is the currently most reserved on VBLT (Vascular Biogenics Ltd)?
